FDAnews Drug Daily Bulletin
Pharmaceuticals / Commercial Operations

Armed With New Patent, Indivior Sues Suboxone Generics Applicants

Feb. 15, 2018
A A

Indivior sued five competitors for infringing on its patent for the Suboxone sublingual film for treatment of opioid dependence.

Suboxone represents 80 percent of Indivior’s revenue, which totaled $275 million for the third quarter of 2017.

The patent at issue relates to polymer film compositions with a substantially uniform distribution of the active drug. The defendants’ proposed Suboxone generics would infringe on the patent, according to Indivior.

View today's stories